[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367222-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367222-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comprehensive-analysis-of-the-multifaceted-role-of-itgav-in-digestive-system-cancer-progression-and-immune-infiltration","Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration","","Digestive system cancers show high incidence and mortality, yet effective detection and treatment targets remain limited. This study investigates ITGAV (integrin av, CD51) as a potential oncogenic driver in digestive malignancies and evaluates its prognostic, diagnostic, and immunological relevance. Transcriptome and clinical data from multiple public databases were integrated with bioinformatics analyses, and functional experiments using hepatocellular and pancreatic cancer models were performed. Results link elevated ITGAV to poor outcomes, early diagnosis potential, and immune cell infiltration patterns.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comprehensive-analysis-of-the-multifaceted-role-of-itgav-in-digestive-system-cancer-progression-and-immune-infiltration/367222/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-the-multifaceted-role-of-itgav-in-digestive-system-cancer-progression-and-immune-infiltration/367222.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the focus of this research on digestive system cancers?","Question",{"text":63,"@type":64},"The study focuses on the multifaceted role of ITGAV in digestive system cancer progression, including prognosis, diagnosis, and immune infiltration.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases and analytical methods were used to study ITGAV?",{"text":68,"@type":64},"Transcriptome and clinical data were retrieved from TCGA, GTEx, HPA, cBioPortal, TIMER, and TISIDB, followed by bioinformatics analyses including GO, KEGG, and PPI network analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"How was ITGAV functionally validated in cancer models?",{"text":72,"@type":64},"The role of ITGAV in cancer progression was experimentally verified using hepatocellular carcinoma and pancreatic cancer models, where ITGAV knockdown inhibited migration and overexpression promoted migration.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367222,1790889003,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 13 February 2025  \nDOI 10.3389/fimmu.2025.1480771  \nOPEN ACCESS  \nEDITED BY  \nPaula Lam,  \nIndependent Researcher, Singapore, Singapore  \nREVIEWED BY  \nSanjima Pal,  \nMcGill University Health Center, Canada Hanyu Zhang,  \nMassachusetts General Hospital and Harvard Medical School, United States  \nXiaolong Wang,  \nQiqihar Medical University, China  \n*CORRESPONDENCE  \nFang Han  \n [hanfang@hit.edu.cn](hanfang@hit.edu.cn)[ ](hanfang@hit.edu.cn)Depeng Yang  \n [ydpgene@hit.edu.cn](ydpgene@hit.edu.cn)[ ](ydpgene@hit.edu.cn)Yu Li  \n [liyugene@hit.edu.cn](liyugene@hit.edu.cn)[ ](liyugene@hit.edu.cn)Huan Nie  \n [nh1212@hit.edu.cn](nh1212@hit.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 14 August 2024  \nACCEPTED 24 January 2025  \nPUBLISHED 13 February 2025  \nCITATION  \nShi X, Zang J, Gu Q, Zhang M, Sun H, Yang L, Cheng J, Wang R, Mao H, Xu A, Wang X, Xiao Y, Cai J, Han F, Yang D, Li Y and Nie H (2025) Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune inﬁltration. Front. Immunol. 16:1480771 .  \ndoi: 10.3389/fimmu.2025.1480771  \nCOPYRIGHT  \n© 2025 Shi, Zang, Gu, Zhang, Sun, Yang, Cheng, Wang, Mao, Xu, Wang, Xiao, Cai, Han, Yang, Li and Nie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune inﬁltration  \nXinyue Shi 1†, Jingyu Zang 1†, Qi Gu 1†, Mengmeng Zhang 1, Handi Sun 1, Lijun Yang 1, Jiahui Cheng 1, Ruonan Wang 1, Han Mao 1, Aitong Xu 1, Xin Wang 1, Yu Xiao 1, Jialing Cai 2, Fang Han 1*, Depeng Yang 1*, Yu Li 1* and Huan Nie 1*  \n1School of Life Science and Technology, Faculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin, Heilongjiang, China, 2 Department of Toxicology, College of Public Health, Harbin Medical University, Harbin, Heilongjiang, China  \nBackground: Digestive system cancers are among the most common malignancies, exhibiting consistently high incidence and mortality rates, yet effective detection and treatment targets remain limited. Integrin av (ITGAV, CD51) is a signiﬁcant member of the integrin family, widely recognized for its role in mediating interactions between cells and the extracellular matrix, as well as intracellular signaling. In recent years, ITGAV has been found to have signiﬁcantly elevated expression in multiple tumors, such as prostate cancer, breast cancer, and osteosarcoma, and was considered to be a key component in various stages of tumor progression. However, no systematic digestive system cancer analysis has been conducted to explore its function in prognosis, diagnosis, and immunology.  \nMethods: Transcriptome sequencing and clinical data of samples were obtained from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression Project (GTEx), Human Protein Atlas (HPA), cBioPortal, TIMER and TISIDB databases. Bioinformatics methods were employed to investigate the potential oncogenicity of ITGAV, focusing speciﬁcally on the analysis of its prognosis, diagnostic value, and immune inﬁltration level of ITGAV in digestive system cancers. In addition, GO, KEGG, and PPI network analysis revealed the biological functions and related signaling pathways related to ITGAV. Finally, the role of ITGAV in regulating cancer progression was experimentally veriﬁed using hepatocellular carcinoma and pancreatic cancer as examples.  \nResults: We found that ITGAV was highly expressed in multiple digestive system cancers. In addition, high expression of ITGAV was closely associated ","cbCaiokJll1iqWyc","https://ap.wps.com/l/cbCaiokJll1iqWyc","pdf",15398572,18,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n## Introduction","[{\"question\":\"What is the focus of this research on digestive system cancers?\",\"answer\":\"The study focuses on the multifaceted role of ITGAV in digestive system cancer progression, including prognosis, diagnosis, and immune infiltration.\"},{\"question\":\"Which databases and analytical methods were used to study ITGAV?\",\"answer\":\"Transcriptome and clinical data were retrieved from TCGA, GTEx, HPA, cBioPortal, TIMER, and TISIDB, followed by bioinformatics analyses including GO, KEGG, and PPI network analyses.\"},{\"question\":\"How was ITGAV functionally validated in cancer models?\",\"answer\":\"The role of ITGAV in cancer progression was experimentally verified using hepatocellular carcinoma and pancreatic cancer models, where ITGAV knockdown inhibited migration and overexpression promoted migration.\"}]","Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration | PDF",1790169762,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd55d3c938d2a01f92e3c4c6f1e9a2e2.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6d0e861cbf124e05c91312057069352.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7606d1e6cbbaa301af2fb3448bd9d76f.webp",981,1386,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd249a4d0fd577d85ea9314ee2d8588f.webp",980,1385]